Skip to main content

Weather alert

Due to Hurricane Isaias, our Patient Service Centers in affected areas may be closed. We ask that patients please double check your appointment status to ensure your designated Patient Service Center is operational. For site-specific information, please use Find a location and enter your zip code.

Hide
Quest Diagnostics

Analysis of Δ8-Tetrahydrocannabinol, Δ9-Tetrahydrocannabinol, and Cannabidiol Metabolites in Authentic Meconium Samples

AAFS 2026

American Academy of Forensic Science

New Orleans, LA, Feb 9-14, 2026

Oral presentation: Analysis of Δ8-Tetrahydrocannabinol, Δ9-Tetrahydrocannabinol, and Cannabidiol Metabolites in Authentic Meconium Samples

Authors: Marco Ballotari, Michael T. Truver, Bruce A. Goldberger, Sarah H. Bartock, Wen Dui, Kay Roussos-Ross

Medical Specialty: Prescription Drug Monitoring, Toxicology, Women's Health, OB, GYN, Pediatrics

Related content

Conference Presentation
Meconium Marijuana Trends: Prevalence of Delta8-THCCOOH
Audio Podcast
Drug Testing Your Patients for Marijuana
Test FAQ
Drug Toxicology Monitoring Oral Fluid Testing

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.